is similarly variable in the human brain, then this variation must be the first consideration in any attempt to estimate brain lesion size. This requires that the lesions must be clearly defined by region. One might expect the direct correlation of brain lesion size in humans with any serum CK isoenzyme values to be of little value until more is known about the distribution of these enzymes in human brain and how they are released. We recently reported a screening procedure for microalbuminuria in which the colorimetry of total protein in an untimed day urine specimen was related to its respective albumin concentration (1). The intra-individual variability, with respect to the initial urinary protein concentrations, however, was not considered. Subsequently, we have estimated urinary protein in 30 diabetic patients who have had at least four repeat measurements during a six-month period. The methodology is as previously described (1), except that the microtiter plate reader was fitted with a filter that allowed measurement of the absorbance at 600 nm, the proteinshifted spectrum maximum (2).
Colorimetric Screening Method for Microalbuminuria: Intra-Individual Variability for Untimed Day Specimens

To the Editor:
We recently reported a screening procedure for microalbuminuria in which the colorimetry of total protein in an untimed day urine specimen was related to its respective albumin concentration (1). The intra-individual variability, with respect to the initial urinary protein concentrations, however, was not considered. Subsequently, we have estimated urinary protein in 30 diabetic patients who have had at least four repeat measurements during a six-month period. The methodology is as previously described (1), except that the microtiter plate reader was fitted with a filter that allowed measurement of the absorbance at 600 nm, the proteinshifted spectrum maximum (2).
Pitman's test for dependence (3) established that there was no significant relation (P >0 
